Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (655)
|
Core Tip (744)
|
Full Article (HTML) (2463)
|
Figures (1-1) (482)
|
Full Article (PDF)-1204K (195)
|
Full Article with Cover (PDF)-11949K (230)
|
Full Article (XML)-236K (122)
|
Audio-1342K (11)
|
Peer-Review Report-230K (131)
|
Answering Reviewers-97K (119)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (7499)
|
Similar Articles (78)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (693)
|
Core Tip (738)
|
Full Article (HTML) (1788)
|
Tables (1-1) (568)
|
Full Article (PDF)-358K (160)
|
Full Article with Cover (PDF)-11106K (200)
|
Full Article (XML)-54K (110)
|
Audio-1072K (10)
|
Peer-Review Report-236K (104)
|
Answering Reviewers-62K (97)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6124)
|
Similar Articles (21)
|
Timeline of Article Publication (1)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions

World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (791)
|
Core Tip (633)
|
Full Article (HTML) (7007)
|
Figures (1-2) (519)
|
Tables (1-5) (519)
|
Full Article (PDF)-1655K (277)
|
Full Article with Cover (PDF)-12399K (226)
|
Full Article (XML)-226K (134)
|
Audio-1259K (9)
|
Peer-Review Report-216K (115)
|
Answering Reviewers-145K (111)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (17)
|
Total Visits (11765)
|
Similar Articles (65)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (768)
|
Core Tip (685)
|
Full Article (HTML) (3762)
|
Figures (1-1) (519)
|
Full Article (PDF)-601K (277)
|
Full Article with Cover (PDF)-11346K (166)
|
Full Article (XML)-89K (120)
|
Audio-384K (10)
|
Peer-Review Report-180K (103)
|
Answering Reviewers-74K (116)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (17)
|
Total Visits (8122)
|
Similar Articles (338)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (735)
|
Core Tip (650)
|
Article Highlights (666)
|
Full Article (HTML) (2546)
|
Figures (1-4) (457)
|
Tables (1-3) (467)
|
Full Article (PDF)-1672K (170)
|
Full Article with Cover (PDF)-12418K (164)
|
Full Article (XML)-173K (105)
|
Audio-467K (7)
|
Peer-Review Report-182K (97)
|
Answering Reviewers-71K (133)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8273)
|
Similar Articles (2062)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes

World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (703)
|
Core Tip (713)
|
Article Highlights (819)
|
Full Article (HTML) (2194)
|
Figures (1-3) (538)
|
Tables (1-2) (501)
|
Full Article (PDF)-1874K (184)
|
Full Article with Cover (PDF)-12619K (198)
|
Full Article (XML)-114K (128)
|
Audio-386K (17)
|
Peer-Review Report-233K (120)
|
Answering Reviewers-161K (117)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (9606)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication

World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (619)
|
Core Tip (589)
|
Article Highlights (661)
|
Full Article (HTML) (1562)
|
Figures (1-4) (439)
|
Full Article (PDF)-5746K (160)
|
Full Article with Cover (PDF)-16492K (149)
|
Full Article (XML)-96K (115)
|
Audio-3997K (8)
|
Peer-Review Report-192K (102)
|
Answering Reviewers-146K (114)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6655)
|
Similar Articles (43)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease

World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (696)
|
Core Tip (672)
|
Article Highlights (702)
|
Full Article (HTML) (2768)
|
Figures (1-4) (440)
|
Tables (1-5) (468)
|
Full Article (PDF)-6006K (199)
|
Full Article with Cover (PDF)-16750K (180)
|
Full Article (XML)-200K (109)
|
Audio-376K (6)
|
Peer-Review Report-182K (119)
|
Answering Reviewers-60K (120)
|
Supplementary Material-355K (115)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (10324)
|
Similar Articles (1910)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis

World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (623)
|
Core Tip (686)
|
Article Highlights (673)
|
Full Article (HTML) (1931)
|
Figures (1-4) (465)
|
Tables (1-4) (457)
|
Full Article (PDF)-5941K (162)
|
Full Article with Cover (PDF)-16687K (159)
|
Full Article (XML)-115K (115)
|
Audio-187K (10)
|
Peer-Review Report-215K (109)
|
Answering Reviewers-37K (127)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8135)
|
Similar Articles (2549)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (661)
|
Core Tip (661)
|
Full Article (HTML) (1679)
|
Figures (1-1) (521)
|
Full Article (PDF)-5068K (188)
|
Full Article with Cover (PDF)-15813K (154)
|
Full Article (XML)-63K (103)
|
Audio-811K (4)
|
Peer-Review Report-266K (123)
|
Answering Reviewers-225K (122)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6961)
|
Similar Articles (4377)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (660)
|
Core Tip (706)
|
Full Article (HTML) (1656)
|
Full Article (PDF)-325K (137)
|
Full Article with Cover (PDF)-11079K (154)
|
Full Article (XML)-24K (112)
|
Audio-243K (4)
|
Peer-Review Report-215K (91)
|
Answering Reviewers-19K (94)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5022)
|
Similar Articles (402)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open